New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 1, 2014
09:27 EDTYRCW, ARRY, GPRO, PXLW, SPWR, WWWW, GALT, DATA, BYD, PG, ARNA, BYI, EXPE, LNKD, HIL, SGMSOn The Fly: Pre-market Movers
HIGHER: Procter & Gamble (PG), up 2.2% after core EPS beat expectations, company announces plans to trim portfolio to 70-80 "core" brands... Expedia (EXPE), up 3.5% after upgraded at Raymond James following better than expected Q2 earnings results... Bally Technologies (BYI), up 31% after Scientific Games (SGMS) to acquire the company for $83.30 per share, or $5.1B. Scientific Games is up 13% after the news... Array BioPharma (ARRY), up 6% after receiving orphan status for ovarian cancer treatment... Tableau (DATA), up 4.5% after upgraded at Mizuho after better than expected Q2 earnings results. UP AFTER EARNINGS: LinkedIn (LNKD), up 8.6%... Arena Pharmaceuticals (ARNA), up 3.5%. DOWN AFTER EARNINGS: GoPro (GPRO), down 10.6%... SunPower (SPWR), down 3.1%... Pixelworks (PXLW), down 16.8%... YRC Worldwide (YRCW), up 15.8%. LOWER: Web.com (WWWW), down 25% after reporting second quarter results and acquiring U.K. online directory company Scoot... Hill International (HIL), down 12.9% after 8.5M share secondary offering priced at $4.25... Boyd Gaming (BYD), down 7.4% after downgraded at Credit Suisse following lower than expected Q2 earnings results... Galectin Therapeutics (GALT), down 4% after downgraded at Aegis... Biota (BOTA), down 33% after IGLOO did not achieve significant reduction in time to alleviation.
News For PG;LNKD;BYI;SGMS;EXPE;ARNA;HIL;WWWW;GPRO;BYD;SPWR;ARRY;DATA;PXLW;YRCW;GALT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
February 23, 2015
11:17 EDTARRYFTC puts conditions on Novartis's proposed acquisition of GSK oncology drugs
According to the FTC, Global pharmaceutical company Novartis (NVS) has agreed to divest all assets related to its BRAF and MEK inhibitor drugs, currently in development, to Boulder, Colorado-based Array BioPharma (ARRY) to settle charges that Novartis’s $16B acquisition of GlaxoSmithKline’s (GSK) portfolio of cancer-treatment drugs would likely be anticompetitive...If the acquisition goes forward as proposed, Novartis would likely delay or terminate development of both its BRAF and MEK inhibitors, as well as the combination product. For that reason, Novartis’s acquisition of GSK’s portfolio of cancer-treatment drugs would likely cause significant competitive harm in the U.S. markets for both the BRAF and MEK inhibitors, ultimately raising prices for consumers and depriving them of potentially superior products. Under the terms of the proposed consent agreement, Novartis is required to provide transitional services to Array BioPharma to ensure that development of the BRAF and MEK inhibitors continues uninterrupted and that competition in BRAF and MEK inhibitor markets is not reduced. Reference Link
07:03 EDTSGMS, BYIScientific Games wins dismissal of patent infringement lawsuit
Subscribe for More Information
February 20, 2015
10:30 EDTBYDOptions with decreasing implied volatility
Subscribe for More Information
10:03 EDTGPROGoPro February calls active
GoPro February 45, 45.5 and February weekly 47 calls are active in total call volume of 5K contracts (1K puts) amid renewed takeover speculation. February weekly call option implied volatility is at 71, March is at 57, April is at 54; compared to its 26-week average of 56 according to Track Data. Active call volume suggests traders taking positions for large near term price movement.
09:48 EDTGPRORumor: GoPro moves higher amid renewed takeover speculation
Subscribe for More Information
09:47 EDTLNKDLinkedIn management to meet with Pacific Crest
Meetings to be held in the Midwest February 26-27 hosted by Pacific Crest.
08:43 EDTSPWRMorgan Stanley still ascribes a 75% probability of a SunPower Yield Co
Subscribe for More Information
07:40 EDTEXPEExpedia price target raised to $102 from $91 at UBS
Subscribe for More Information
05:18 EDTEXPEStocks with implied volatility below IV index mean; EXPE TRIP
Stocks with implied volatility below IV index mean; Expedia (EXPE) 28, TripAdvisor (TRIP) 33 according to iVolatility.
February 19, 2015
13:18 EDTSPWRIsrael's SolarEdge to launch IPO
Subscribe for More Information
13:04 EDTSPWRDeutsche, Canaccord still upbeat on SolarCity despite Q1 guidance miss
The shares of SolarCity (SCTY) are falling after the company reported a higher than expected fourth quarter loss. However, Deutsche Bank and research firm Canaccord remained upbeat on the stock in notes to investors earlier today. Solarcity installs solar energy systems at residences and businesses. BACKGROUND: SolarCity reported a Q4 loss of ($1.33) per share, versus the consensus outlook for a ($1.27) per share loss. SolarCity's Q4 revenue, however, was roughly in-line with expectations and the company said that its backlog as of the beginning of 2015 was large enough to cover much of its expected installations for the first half of the year. Additionally, SolarCity reiterated its guidance for 920-1000MW of solar installations for 2015. SolarCity estimated, however, that its Q1 per share loss would come in at ($1.65)-($1.75), versus the consensus outlook for a ($1.25) per share loss. ANALYST REACTION: Deutsche Bank analyst Vishal Shah wrote that SolarCity had executed well, while demand for its installations is strong. Moreover, the company's cost reduction plan looks to be running ahead of schedule, and its 2015 shipments look poised to come in ahead of its guidance, Shah believes. The analyst did, however, write that SolarCity's Q4 bookings were "somewhat" below his expectations and declined versus Q3. Nonetheless, the analyst continued to identify the stock as one of his top picks in the solar sector and kept a $90 price target and Buy rating on the name. Also upbeat on SolarCity was Canaccord analyst Jed Dorsheimer. He raised his price target on the shares to $67 from $64 following its results. SolarCity has had record bookings over the last 30 days and the company should come close to setting a bookings record in Q1, the analyst wrote, adding that its deployments should ramp in Q2 and Q3 as seasonal factors subside. Dorsheimer kept a Buy rating on the stock. PRICE ACTION: In early afternoon trading, SolarCity fell 6.3% to $53.48. Other names in the solar sector also declined, with SunPower (SPWR) falling 1.8%, JinkoSolar (JKS) dropping 1.5%, and Vivint Solar (VSLR) losing 2.3%.
09:37 EDTPGProcter & Gamble sese core EPS 'meaningfully' improving in 2H
Subscribe for More Information
09:35 EDTSPWROption volume leaders
Option volume leaders: AAPL TSLA TWTR MCD WMT PBR SPWR WFM GILD FB SCTY according to Track Data.
09:21 EDTPGProcter & Gamble repeats FY15 currency neutral core EPS growth view
Subscribe for More Information
07:17 EDTEXPEMaxim to hold a bus tour
Internet/Tech Bus Tour travels throughout Seattle, Washington to various with various industry companies on February 19.
05:34 EDTEXPEStocks with implied volatility below IV index mean; EXPE BBRY
Subscribe for More Information
February 18, 2015
18:22 EDTSPWRSolar stocks struggle in extended session after SolarCity results
Solar stocks are trading down in the extended session after SolarCity (SCTY) reported a larger fourth quarter loss than expected and guided to a first quarter loss well below consensus estimates. WHAT'S NEW: Solar city said adjusted non-GAAP earnings per share for Q4 was a loss of ($1.33) against estimates of a loss of ($1.27). Revenue for the quarter was in-line at $71.8M. The company also guided for a loss of ($1.75)-($1.65) per share in the current quarter which is below analysts' average estimates for a loss of ($1.25) per share. However, the company did note, " With end-market demand healthy and growing, our installation capacity steadily ramping and a majority of our financing needs secured for the year, we remain confident in achieving our guidance to deploy 920-1000MW in 2015." PRICE ACTION: Shares of SolarCity are down over 5% to $54.01 in the after-hours session. OTHERS TO WATCH: Other stocks in the solar space trading lower in the extended session include SunPower (SPWR), SunEdison (SUNE), Vivint Solar (VSLR), and First Solar (FSLR).
09:37 EDTLNKDOption volume leaders on open
Option volume leaders: AAPL TSLA TWTR CELG APO NFLX AXP APA LNKD C GILD according to Track Data.
09:06 EDTHILHill International receives $30M ID/IQ contract from GSA Region 3
Subscribe for More Information
03:20 EDTGPROOn The Fly: Analyst Initiation Summary
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use